Oppenheimer & Co’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
18,421
-3,825
| -17% | -$281K | 0.02% | 724 |
|
|
2025
Q1 | $2.54M | Buy |
22,246
+6,246
| +39% | +$713K | 0.04% | 479 |
|
|
2024
Q4 | $806K | Sell |
16,000
-8,774
| -35% | -$442K | 0.01% | 887 |
|
|
2024
Q3 | $1.15M | Buy |
24,774
+4,774
| +24% | +$221K | 0.02% | 743 |
|
|
2024
Q2 | $650K | Hold |
20,000
| – | – | 0.01% | 917 |
|
|
2024
Q1 | $504K | Hold |
20,000
| – | – | 0.01% | 984 |
|
|
2023
Q4 | $650K | Hold |
20,000
| – | – | 0.01% | 876 |
|
|
2023
Q3 | $545K | Hold |
20,000
| – | – | 0.01% | 907 |
|
|
2023
Q2 | $445K | Hold |
20,000
| – | – | 0.01% | 1015 |
|
|
2023
Q1 | $433K | Hold |
20,000
| – | – | 0.01% | 997 |
|
|
2022
Q4 | $406K | Hold |
20,000
| – | – | 0.01% | 977 |
|
|
2022
Q3 | $513K | Hold |
20,000
| – | – | 0.01% | 890 |
|
|
2022
Q2 | $476K | Sell |
20,000
-2,000
| -9% | -$47.6K | 0.01% | 939 |
|
|
2022
Q1 | $495K | Buy |
+22,000
| New | +$495K | 0.01% | 1006 |
|
|
2021
Q4 | – | Sell |
-20,000
| Closed | -$394K | – | 1499 |
|
|
2021
Q3 | $394K | Hold |
20,000
| – | – | 0.01% | 1113 |
|
|
2021
Q2 | $440K | Buy |
+20,000
| New | +$440K | 0.01% | 1089 |
|
|
2016
Q1 | – | Sell |
-20,000
| Closed | -$100K | – | 1257 |
|
|
2015
Q4 | $100K | Hold |
20,000
| – | – | ﹤0.01% | 1207 |
|
|
2015
Q3 | $75K | Buy |
+20,000
| New | +$75K | ﹤0.01% | 1288 |
|